High heritability and genetic correlation of intravenous glucose- and tolbutamide-induced insulin secretion among non-diabetic family members of type 2 diabetic patients

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

High heritability and genetic correlation of intravenous glucose- and tolbutamide-induced insulin secretion among non-diabetic family members of type 2 diabetic patients. / Gjesing, Anette Marianne Prior; Hornbak, Malene; Allin, Kristine H.; Ekstrøm, Claus Thorn; Urhammer, Søren A.; Eiberg, Hans; Pedersen, Oluf; Hansen, Torben.

In: Diabetologia, Vol. 57, No. 6, 06.2014, p. 1173-1181.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Gjesing, AMP, Hornbak, M, Allin, KH, Ekstrøm, CT, Urhammer, SA, Eiberg, H, Pedersen, O & Hansen, T 2014, 'High heritability and genetic correlation of intravenous glucose- and tolbutamide-induced insulin secretion among non-diabetic family members of type 2 diabetic patients', Diabetologia, vol. 57, no. 6, pp. 1173-1181. https://doi.org/10.1007/s00125-014-3207-y

APA

Gjesing, A. M. P., Hornbak, M., Allin, K. H., Ekstrøm, C. T., Urhammer, S. A., Eiberg, H., Pedersen, O., & Hansen, T. (2014). High heritability and genetic correlation of intravenous glucose- and tolbutamide-induced insulin secretion among non-diabetic family members of type 2 diabetic patients. Diabetologia, 57(6), 1173-1181. https://doi.org/10.1007/s00125-014-3207-y

Vancouver

Gjesing AMP, Hornbak M, Allin KH, Ekstrøm CT, Urhammer SA, Eiberg H et al. High heritability and genetic correlation of intravenous glucose- and tolbutamide-induced insulin secretion among non-diabetic family members of type 2 diabetic patients. Diabetologia. 2014 Jun;57(6):1173-1181. https://doi.org/10.1007/s00125-014-3207-y

Author

Gjesing, Anette Marianne Prior ; Hornbak, Malene ; Allin, Kristine H. ; Ekstrøm, Claus Thorn ; Urhammer, Søren A. ; Eiberg, Hans ; Pedersen, Oluf ; Hansen, Torben. / High heritability and genetic correlation of intravenous glucose- and tolbutamide-induced insulin secretion among non-diabetic family members of type 2 diabetic patients. In: Diabetologia. 2014 ; Vol. 57, No. 6. pp. 1173-1181.

Bibtex

@article{8e1993664613494ebb5bde6f78c2ab3c,
title = "High heritability and genetic correlation of intravenous glucose- and tolbutamide-induced insulin secretion among non-diabetic family members of type 2 diabetic patients",
abstract = "Aims/hypothesis: The aim of this study was to estimate the heritability of quantitative measures of glucose regulation obtained from a tolbutamide-modified frequently sampled IVGTT (t-FSIGT) and to correlate the heritability of the glucose-stimulated beta cell response to the tolbutamide-induced beta cell response. In addition, single nucleotide polymorphisms (SNPs) having an exclusive effect on either glucose- or tolbutamide-stimulated insulin release were identified. Methods: Two hundred and eighty-four non-diabetic family members of patients with type 2 diabetes underwent a t-FSIGT with intravenous injection of glucose at t∈=∈0 min and tolbutamide at t∈=∈20 min. Measurements of plasma glucose, serum insulin and serum C-peptide were taken at 33 time points from fasting to 180 min. Insulin secretion rate, acute insulin response (AIR), disposition index (DI) after glucose and disposition index after tolbutamide (DIT), insulin sensitivity (SI), glucose effectiveness (SG) and beta cell responsiveness to glucose were calculated. A polygenic variance component model was used to estimate heritability, genetic correlations and associations. Results: We found high heritabilities for acute insulin secretion subsequent to glucose stimulation (AIRglucose h 2∈±∈SE: 0.88∈±∈0.14), but these were slightly lower after tolbutamide (AIRtolbutamide h 2∈±∈SE: 0.69∈±∈0.14). We also estimated the heritabilities for S I (h 2∈±∈SE: 0.26∈±∈0. 12), SG (h 2∈±∈SE: 0. 47∈±∈0.13), DI (h 2∈±∈ SE: 0.56∈±∈0.14), DIT (h 2∈±∈SE: 0.49∈±∈0.14) and beta cell responsiveness to glucose (h 2∈±∈SE: 0.66∈±∈0.12). Additionally, strong genetic correlations were found between measures of beta cell response after glucose and tolbutamide stimulation, with correlation coefficients ranging from 0.77 to 0.88. Furthermore, we identified five SNPs with an exclusive effect on either glucose-stimulated (rs5215, rs1111875, rs11920090) or tolbutamide-stimulated (rs10946398, rs864745) insulin secretion. Conclusions/interpretation: Our data demonstrate that both glucose- and tolbutamide-induced insulin secretions are highly heritable traits, which are largely under the control of the same genes.",
keywords = "Acute insulin response, Genetic correlation, Heritability, Tolbutamide-modified frequently sampled intravenous glucose tolerance test, Type 2 diabetes",
author = "Gjesing, {Anette Marianne Prior} and Malene Hornbak and Allin, {Kristine H.} and Ekstr{\o}m, {Claus Thorn} and Urhammer, {S{\o}ren A.} and Hans Eiberg and Oluf Pedersen and Torben Hansen",
year = "2014",
month = jun,
doi = "10.1007/s00125-014-3207-y",
language = "English",
volume = "57",
pages = "1173--1181",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer",
number = "6",

}

RIS

TY - JOUR

T1 - High heritability and genetic correlation of intravenous glucose- and tolbutamide-induced insulin secretion among non-diabetic family members of type 2 diabetic patients

AU - Gjesing, Anette Marianne Prior

AU - Hornbak, Malene

AU - Allin, Kristine H.

AU - Ekstrøm, Claus Thorn

AU - Urhammer, Søren A.

AU - Eiberg, Hans

AU - Pedersen, Oluf

AU - Hansen, Torben

PY - 2014/6

Y1 - 2014/6

N2 - Aims/hypothesis: The aim of this study was to estimate the heritability of quantitative measures of glucose regulation obtained from a tolbutamide-modified frequently sampled IVGTT (t-FSIGT) and to correlate the heritability of the glucose-stimulated beta cell response to the tolbutamide-induced beta cell response. In addition, single nucleotide polymorphisms (SNPs) having an exclusive effect on either glucose- or tolbutamide-stimulated insulin release were identified. Methods: Two hundred and eighty-four non-diabetic family members of patients with type 2 diabetes underwent a t-FSIGT with intravenous injection of glucose at t∈=∈0 min and tolbutamide at t∈=∈20 min. Measurements of plasma glucose, serum insulin and serum C-peptide were taken at 33 time points from fasting to 180 min. Insulin secretion rate, acute insulin response (AIR), disposition index (DI) after glucose and disposition index after tolbutamide (DIT), insulin sensitivity (SI), glucose effectiveness (SG) and beta cell responsiveness to glucose were calculated. A polygenic variance component model was used to estimate heritability, genetic correlations and associations. Results: We found high heritabilities for acute insulin secretion subsequent to glucose stimulation (AIRglucose h 2∈±∈SE: 0.88∈±∈0.14), but these were slightly lower after tolbutamide (AIRtolbutamide h 2∈±∈SE: 0.69∈±∈0.14). We also estimated the heritabilities for S I (h 2∈±∈SE: 0.26∈±∈0. 12), SG (h 2∈±∈SE: 0. 47∈±∈0.13), DI (h 2∈±∈ SE: 0.56∈±∈0.14), DIT (h 2∈±∈SE: 0.49∈±∈0.14) and beta cell responsiveness to glucose (h 2∈±∈SE: 0.66∈±∈0.12). Additionally, strong genetic correlations were found between measures of beta cell response after glucose and tolbutamide stimulation, with correlation coefficients ranging from 0.77 to 0.88. Furthermore, we identified five SNPs with an exclusive effect on either glucose-stimulated (rs5215, rs1111875, rs11920090) or tolbutamide-stimulated (rs10946398, rs864745) insulin secretion. Conclusions/interpretation: Our data demonstrate that both glucose- and tolbutamide-induced insulin secretions are highly heritable traits, which are largely under the control of the same genes.

AB - Aims/hypothesis: The aim of this study was to estimate the heritability of quantitative measures of glucose regulation obtained from a tolbutamide-modified frequently sampled IVGTT (t-FSIGT) and to correlate the heritability of the glucose-stimulated beta cell response to the tolbutamide-induced beta cell response. In addition, single nucleotide polymorphisms (SNPs) having an exclusive effect on either glucose- or tolbutamide-stimulated insulin release were identified. Methods: Two hundred and eighty-four non-diabetic family members of patients with type 2 diabetes underwent a t-FSIGT with intravenous injection of glucose at t∈=∈0 min and tolbutamide at t∈=∈20 min. Measurements of plasma glucose, serum insulin and serum C-peptide were taken at 33 time points from fasting to 180 min. Insulin secretion rate, acute insulin response (AIR), disposition index (DI) after glucose and disposition index after tolbutamide (DIT), insulin sensitivity (SI), glucose effectiveness (SG) and beta cell responsiveness to glucose were calculated. A polygenic variance component model was used to estimate heritability, genetic correlations and associations. Results: We found high heritabilities for acute insulin secretion subsequent to glucose stimulation (AIRglucose h 2∈±∈SE: 0.88∈±∈0.14), but these were slightly lower after tolbutamide (AIRtolbutamide h 2∈±∈SE: 0.69∈±∈0.14). We also estimated the heritabilities for S I (h 2∈±∈SE: 0.26∈±∈0. 12), SG (h 2∈±∈SE: 0. 47∈±∈0.13), DI (h 2∈±∈ SE: 0.56∈±∈0.14), DIT (h 2∈±∈SE: 0.49∈±∈0.14) and beta cell responsiveness to glucose (h 2∈±∈SE: 0.66∈±∈0.12). Additionally, strong genetic correlations were found between measures of beta cell response after glucose and tolbutamide stimulation, with correlation coefficients ranging from 0.77 to 0.88. Furthermore, we identified five SNPs with an exclusive effect on either glucose-stimulated (rs5215, rs1111875, rs11920090) or tolbutamide-stimulated (rs10946398, rs864745) insulin secretion. Conclusions/interpretation: Our data demonstrate that both glucose- and tolbutamide-induced insulin secretions are highly heritable traits, which are largely under the control of the same genes.

KW - Acute insulin response

KW - Genetic correlation

KW - Heritability

KW - Tolbutamide-modified frequently sampled intravenous glucose tolerance test

KW - Type 2 diabetes

U2 - 10.1007/s00125-014-3207-y

DO - 10.1007/s00125-014-3207-y

M3 - Journal article

C2 - 24604100

AN - SCOPUS:84901204547

VL - 57

SP - 1173

EP - 1181

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 6

ER -

ID: 135219152